Safety & side effects Common side effects The most common side effects are gastrointestinal, nausea, diarrhea, vomiting, and constipation, usually mild to moderate and most likely while your dose is being increased
Studies suggest that up to 70% of people experience some form of GI symptoms, especially when starting treatment or increasing their dose
The defendant corporationslike Novo Nordiskhave until December 23, 2024, to file their initial expert reports
Previous studies have demonstrated that BPC-157 promotes the healing of different tissues, including skin,36 muscle,15,3739 bone,40 ligament,41 and tendon42 in various animal models
These fragments may bind HLA Class II molecules and subsequently stimulate CD4+ T-helper cell responses